At 80 weeks, retatrutide met primary endpoints, delivering significant improvements in sleep apnea severity
Disrupting MYSM1 (Myb like, SWIRM and MPN domains 1), a histone deubiquitinase, can compromise human HSC function, mimicking the bone marrow failure seen in patients, by triggering lipid peroxidation and ferroptosis [203]
Cardiovascular effects: Transient changes in blood pressure and heart rate may occur during administration
The search included terms such as small molecule GLP-1 receptor agonists, oral GLP-1 receptor agonists, Danuglipron, Orforglipron, and Aleniglipron. Additionally, information on ongoing clinical trials involving small molecule GLP-1 receptor agonists was retrieved from the ClinicalTrials.gov database using the same keywords
When you get a call about a patient with low potassium (hypokalemia) especially in a critical area most people immediately think of IV replacement